By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Innovus Pharma 

4275 Executive Square
Suite 200
La Jolla  California  92037  U.S.A.
Phone: 858-964-5123 Fax: 858-964-2301



Company News
Innovus Pharma’s Partner Luminarie Receives Approval For Zestra For Female Sexual Arousal Disorder As A Medical Device I From New Zealand’s Medicines And Medical Devices Safety Authority 9/20/2017 7:12:06 AM
Innovus Pharma Announces The Launch Of Zestra In France, Belgium And Monaco By Its Partner, Densmore 9/19/2017 7:46:34 AM
Innovus Pharma Receives Approval From Health Canada For Its Urivarx Product For The Indication To Reduce Symptoms Of Overactive Bladder Such As Daytime Urinary Frequency, Urgency And Nocturia 9/6/2017 9:12:31 AM
Innovus Pharma Files Product License Application For The Commercialization Of Its Seasonal Allergic Rhinitis Product In Canada 8/24/2017 8:15:47 AM
Innovus Pharma Reports A Quarterly Net Revenue Increase Of 99.2% And Net Loss Decrease Of 74.1% Compared To The Same Period In 2016 8/15/2017 6:54:49 AM
Innovus Pharma Orders Its First Commercial Batch Of 220,000 Units Of Fluticare 8/9/2017 7:55:11 AM
Innovus Pharma To Release Second Quarter 2017 Financial Results And Provide Corporate Update On Monday, August 14, 2017 8/2/2017 8:10:32 AM
Innovus Pharma Files Its Product License Application In Canada For The Commercialization Of Its Drug Xyralid 7/31/2017 7:11:23 AM
Innovus Pharma Expands Exclusive License And Distribution Agreement With Densmore For Zestra To Singapore And Vietnam 7/26/2017 6:27:07 AM
Innovus Pharma Announces Combined Launch Of Apeaz Cream For Arthritis Pain Relief, And Arthrivarx, A Supplement Designed To Maximize And Support Joint Health 7/24/2017 9:40:54 AM